Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 128 publications
Nef and Vpu protect infected cells from ADCP mediated by plasma from people with HIV-1.
Journal: mBio
Published: July 29, 2026
Nef and Vpu protect infected cells from ADCP mediated by plasma from people with HIV-1.
Journal: bioRxiv : the preprint server for biology
Published: May 25, 2026
mGem: Opening Env and harnessing NK cell effector functions to eliminate HIV-1-infected cells.
Journal: mBio
Published: March 03, 2026
The emerging role of small CD4 mimetic compounds in HIV-1 immunotherapy.
Journal: Current opinion in HIV and AIDS
Published: October 23, 2025
The HIV-1 envelope cytoplasmic tail protects infected cells from ADCC by downregulating CD4.
Journal: mBio
Published: September 08, 2025
The HIV-1 envelope cytoplasmic tail protects infected cells from ADCC by downregulating CD4.
Journal: bioRxiv : the preprint server for biology
Published: June 12, 2025
Fostemsavir Decreases the Levels of Anti-gp120 CD4-Induced Antibodies in Heavily Treatment-Experienced People With HIV.
Journal: The Journal of infectious diseases
Published: April 14, 2025
CD4 T cell counts are inversely correlated with anti-cluster A antibodies in antiretroviral therapy-treated PLWH.
Journal: medRxiv : the preprint server for health sciences
Published: March 10, 2025
The asymmetric opening of HIV-1 Env by a potent CD4 mimetic enables anti-coreceptor binding site antibodies to mediate ADCC.
Journal: Nature communications
Published: September 12, 2024
Last Updated: 09/26/2026